Intervention for Fear of Childbirth in High-Risk Pregnant Women
Launched by KOCAELI UNIVERSITY · Nov 29, 2024
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Aim: The aim of the study is to examine the effect of mandala activity applied to pregnant women hospitalized in the clinic due to high-risk pregnancies on pregnancy stress and fear of birth.
Hypothesis 1 H.0: There is no difference in pregnancy stress scores between high-risk pregnant women who participated in the mandala study applied in addition to medical treatment in the hospital and high-risk pregnant women who did not.
H.1: There is a difference in pregnancy stress scores between high-risk pregnant women who participated in the mandala study applied in addition to medical treatment...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Those who want to participate in the study voluntarily
- • Those who can speak and understand Turkish
- • Those who are over 18 years of age
- • Primiparous pregnant women
- • Pregnant women diagnosed with risky pregnancies (threatened preterm labor, premature rupture of membranes, gestational hypertension, intrauterine growth retardation, placenta previa, hyperemesis gravidarum)
- • Pregnant women in the second and third trimesters of pregnancy (13-40 weeks)
- • Those who do not have hearing, comprehension and vision problems so that they can follow the group study will be included in the study.
- Exclusion Criteria:
- • Pregnant women who are absent from the mandala activity planned 3 times a week for 4 weeks for more than a week
- • Those who do less than 18 mandala activities during 4 weeks
- • Those who fill out the survey forms incompletely
- • Pregnant women who decide to give birth during the survey period will be excluded from the study.
About Kocaeli University
Kocaeli University, a prominent institution in Turkey, is dedicated to advancing medical research and education through its comprehensive clinical trial initiatives. With a focus on innovative healthcare solutions, the university collaborates with leading researchers and healthcare professionals to conduct rigorous scientific studies aimed at improving patient outcomes. By fostering an environment of academic excellence and interdisciplinary collaboration, Kocaeli University aims to contribute significantly to the global medical community while ensuring adherence to ethical standards and regulatory guidelines in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kocaeli, , Turkey
Patients applied
Trial Officials
Sena Dilek Aksoy, Ph.D.
Principal Investigator
Kocaeli University
Sena Ozen
Study Chair
Kocaeli City Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported